EUVIMEDEUVIMED entdecken
Multizentrische Studie

Low-molecular-weight heparin and respiratory failure in hypertriglyceridemia-associated acute pancreatitis

Feng Deng, Ling Ding, Yuan-Yuan Du, Zhi-Guo Hu, Tong-Bang Zong, Lu Ke, Long-Xiang Cao, Jing-Kang Zhu, Zhen-Guo Zeng, Chinese Acute Pancreatitis Clinical Trials Group (CAPCTG)

Pancreatology · 2026-06 · 26 (4) · 566-572

DOI: 10.1016/j.pan.2026.03.020 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pancreatology, 2026-06. Verfasst von Feng Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Pancreatitis, Respiratory Insufficiency, Heparin, Low-Molecular-Weight, Hypertriglyceridemia. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND The role of low-molecular-weight heparin (LMWH) in preventing respiratory failure among patients with hypertriglyceridemia-associated acute pancreatitis (HTG-AP) remains uncertain. We aimed to examine the association between LMWH use and respiratory failure in HTG-AP. METHODS This post-hoc analysis was based on a multicenter, prospective cohort. Adult patients with HTG-AP (plasma triglycerides >11.3 mmol/L) admitted within 72 h of onset between February 2020 and July 2023 were included. Patients receiving LMWH during the first week were classified as the LMWH group, and those without LMWH served as controls. The primary outcome was defined as new-onset respiratory failure within 14 days of enrollment. Multivariate logistic regression and inverse probability of treatment weighting (IPTW) were applied to adjust for confounders. RESULTS A total of 387 patients (287 [74.2%] male; median [IQR] age, 37 [32-44] years) were enrolled, including 326 in the LMWH group and 61 controls. Of the LMWH group, 260 (79.8%) received LMWH at baseline, and most (295 [90.5%]) received LMWH for >2 days. LMWH use was associated with a reduced risk of respiratory failure (including baseline and post-enrollment cases) (adjusted OR 0.42, 95% CI 0.23-0.76; P = 0.004) and specifically new-onset respiratory failure (i.e., developed after enrollment, adjusted OR 0.46, 95% CI 0.23-0.94; P = 0.033). Longer time from onset to enrollment, higher total bilirubin, and higher APACHE II score were also predictors of respiratory failure. IPTW analysis confirmed these findings. CONCLUSIONS LMWH use may be associated with a lower incidence of respiratory failure in HTG-AP. These findings warrant confirmation in a randomized controlled trial.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PancreatitisRespiratory InsufficiencyHeparin, Low-Molecular-WeightHypertriglyceridemiaAnticoagulantsHumansMaleFemaleProspective StudiesAdultAcute Disease

Stichwörter der Autor:innen

Acute pancreatitisHypertriglyceridemia-associated acute pancreatitisLow-molecular-weight heparinRespiratory failure

Substanzen

Heparin, Low-Molecular-WeightAnticoagulants

Autor:innen und Institutionen

  • Department of Critical Care Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Critical Care Medicine, Jinling Hospital, Medical School of Nanjing University, Nanjing, China; National Institute of Healthcare Data Science, Nanjing University, Nanjing, China.
  • Department of Critical Care Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China. Electronic address: ndyfy08836@ncu.edu.cn.
  • Department of Critical Care Medicine, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China; Medical Center of Anesthesiology and Pain, The First Affiliated Hospital, Jiangxi Medic…

Zitieren

APA

Deng, F., Ding, L., Du, Y. Y., Hu, Z. G., Zong, T. B., Ke, L., Cao, L. X., Zhu, J. K., Zeng, Z. G., & Chinese Acute Pancreatitis Clinical Trials Group (CAPCTG) (2026). Low-molecular-weight heparin and respiratory failure in hypertriglyceridemia-associated acute pancreatitis. Pancreatology, 26(4), 566-572. https://doi.org/10.1016/j.pan.2026.03.020

Vancouver

Deng F, Ding L, Du YY, Hu ZG, Zong TB, Ke L, et al. Low-molecular-weight heparin and respiratory failure in hypertriglyceridemia-associated acute pancreatitis. Pancreatology. 2026;26(4):566-572. doi:10.1016/j.pan.2026.03.020

BibTeX
@article{Deng2026,
  author = {Deng, Feng and Ding, Ling and Du, Yuan-Yuan and Hu, Zhi-Guo and Zong, Tong-Bang and Ke, Lu and Cao, Long-Xiang and Zhu, Jing-Kang and Zeng, Zhen-Guo and Chinese Acute Pancreatitis Clinical Trials Group (CAPCTG), Chinese Acute Pancreatitis Clinical Trials Group (CAPCTG)},
  title = {Low-molecular-weight heparin and respiratory failure in hypertriglyceridemia-associated acute pancreatitis},
  journal = {Pancreatology},
  year = {2026},
  volume = {26},
  number = {4},
  pages = {566--572},
  doi = {10.1016/j.pan.2026.03.020}
}
Kostenlos starten →